Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Buttgereit

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|August 3, 2019
How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and AnswersMurat Türk, Leonor Carneiro-Leão, Pavel Kolkhir, et al.
Allergy|July 13, 2023
Urticaria Control Test real-world performance: A post-hoc analysisPascale Salameh, Annika Gutsche, Felix Aulenbacher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 26, 2019
Thomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2019
Effective treatment of a lymphocytic variant of hypereosinophilic syndrome with reslizumabThomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Frontiers in Medicine|December 19, 2022
Case report: Recurrent angioedema: Diagnosing the rare and the frequentThomas Buttgereit, Lauré M Fijen, Carolina Vera, et al.
Allergy|November 3, 2023
Response to "Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes"Annika Gutsche, Pascale Salameh, Felix Aulenbacher, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
The 7-day recall period version of the Urticaria Control Test-UCT7Thomas Buttgereit, Pascale Salameh, Olga Sydorenko, et al.
Frontiers in Immunology|November 5, 2021
Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human MonocytesPierre-Louis Krauss, Moritz Pfeiffenberger, Alexandra Damerau, et al.
Arthritis Care & Research|August 18, 2019
Association Between Participant Retention and the Proportion of Included Elderly People in Rheumatology Trials: Results From a Series of Exploratory Meta-Regression AnalysesAndriko Palmowski, Sabrina M Nielsen, Thomas Buttgereit, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology. in Practice|August 3, 2019
How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and AnswersMurat Türk, Leonor Carneiro-Leão, Pavel Kolkhir, et al.
Allergy|July 13, 2023
Urticaria Control Test real-world performance: A post-hoc analysisPascale Salameh, Annika Gutsche, Felix Aulenbacher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 26, 2019
Thomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 4, 2019
Effective treatment of a lymphocytic variant of hypereosinophilic syndrome with reslizumabThomas Buttgereit, Hanna Bonnekoh, Martin K Church, et al.
Frontiers in Medicine|December 19, 2022
Case report: Recurrent angioedema: Diagnosing the rare and the frequentThomas Buttgereit, Lauré M Fijen, Carolina Vera, et al.
Allergy|November 3, 2023
Response to "Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes"Annika Gutsche, Pascale Salameh, Felix Aulenbacher, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
The 7-day recall period version of the Urticaria Control Test-UCT7Thomas Buttgereit, Pascale Salameh, Olga Sydorenko, et al.
Frontiers in Immunology|November 5, 2021
Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human MonocytesPierre-Louis Krauss, Moritz Pfeiffenberger, Alexandra Damerau, et al.
Arthritis Care & Research|August 18, 2019
Association Between Participant Retention and the Proportion of Included Elderly People in Rheumatology Trials: Results From a Series of Exploratory Meta-Regression AnalysesAndriko Palmowski, Sabrina M Nielsen, Thomas Buttgereit, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Pageof 6